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Abstract
Background: The present report was designed to investigate the origins of elevated oxidative stress measured in
cancer patients in our previous work related to a case-control study (17 cases, 43 controls) on oesophageal
cancers. The aim was to characterize the relationship between the levels of 8-oxo-7,8-dihydro-2’-deoxyguanosine
(8-oxodG), antioxidant vitamins and genetic susceptibility.
Methods: 8-oxodG was analysed in peripheral blood mononuclear cells (PBMCs) by High Performance Liquid
Chromatography with Electrochemical Detection (HPLC-ED). Analysis of gene polymorphisms in GSTM1 and GSTT1
was performed by multiplex PCR and in GSTP1 and hOGG1 by a PCR-RFLP method. Reversed-phase HPLC with UV
detection at 294 nm was used to measure vitamins A and E in serum from the same blood samples.
Results: We observed that in our combined population (cases and control, n = 60), there was no statistically
significant correlation between the levels of 8-oxodG and (i) the serum concentration of antioxidant vitamins,
vitamin A (P = 0.290) or vitamin E (P = 0.813), or (ii) the incidence of the Ser326Cys polymorphic variant (P = 0.637)
of the hOGG1 gene. Also, the levels of 8-oxodG were not significantly associated with polymorphisms in
metabolite-detoxifying genes, such as GSTs, except for the positive correlation with Val/Val GST P1 allele (P <
0.0001).
Conclusions: The weakness of our cohort size notwithstanding, vitamins levels in serum and genetic
polymorphisms in the hOGG1 or GST genes do not appear to be important modulators of 8-oxodG levels.
Background
Oesophageal cancer remains an important public health
concern worldwide with an estimated burden of 500,
000 new cases in 2005 [1]. The two major histological
types of oesophageal cancers, squamous cell carcinoma
(SCC) and adenocarcinoma (ADC) differ substantially in
their underlying patterns of incidence and key etiologic
factors. Alcoholism and smoking are the major estab-
lished risk factors for SCC, whereas Barrett’s oesophagus
or gastro-oesophageal reflux disease (GORD) are consis-
tently associated with an increased risk of ADC.
Oxidative stress and reactive oxygen species (ROS) are
thought to play a role in oesophageal carcinogenesis.
ROS may result from external factors such as smoking,
and alcohol metabolism, or may be produced endogen-
ously via inflammatory conditions such as oesophagitis
or GORD or may also be due to precancerous lesions
(Barrett’s oesophagus), as has been shown experi-
mentally in rats [2,3]. Diet influences incidence of
* Correspondence: virginie.prevost@unicaen.fr
1Groupe Régional d’Etudes sur le Cancer - UPRES EA 1772 - IFR 146,
Université de Caen - Basse-Normandie and Centre de Lutte Contre le Cancer
François Baclesse, Caen, France
Full list of author information is available at the end of the article
Lagadu et al. Journal of Experimental & Clinical Cancer Research 2010, 29:157
http://www.jeccr.com/content/29/1/157
© 2010 Lagadu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.oesophageal cancers. An adequate diet of fruits and
vegetables is associated with a decreased incidence [4],
presumably due to a better supply of antioxidants.
Among the various markers of oxidative stress, 8-oxo-
7,8-dihydro-2’-deoxyguanosine (8-oxodG) is particularly
popular. It is generated by the oxidation of DNA under
physiopathological conditions or environmental stress,
but is also a by-product of normal cellular metabolism.
It is a premutagenic oxidized-DNA lesion as it is able to
mispair with adenine, thus generating G:C to T:A trans-
version mutations, unless the lesion is repaired prior to
DNA replication [5]. Moreover, affordable analytical
methods are available for its quantification. In popula-
tion studies, 8-oxodG is often determined in DNA
extracted from white blood cells, peripheral blood
mononuclear cells (PBMC) or lymphocytes, although
PBMCs being mostly lymphocytes, the distinction is
rarely made. These cells are considered to be represen-
tative of the whole organism in terms of the level of
exposure of to oxidative stress. However, it has been
suggested that the apparent high levels of 8-oxodG
could be due to artefactual oxidation of DNA during
the treatment of the samples. The European Standards
Committee on Oxidative DNA Damage (ESCODD) has
now been set up within the European laboratory net-
work to improve and harmonise 8-oxodG measurement
methods [6-9].
In a previous study [10], we have described the opti-
misation of an analytical procedure to measure 8-oxodG
in PBMCs by using HPLC coupled with electrochemical
detection (HPLC-ED). In that study [10], the protocol
was applied to the analysis of 8-oxodG in PBMCs of
subjects (n = 60) from a case-control study that
included both, SCC and ADC cases. Control samples (n
= 43) exhibited 4.9 ± 1.9 molecules of 8-oxodG per 10
6
unaltered guanosines, levels which correspond to the
median values reported by the latest ESCODD trial for
HPLC measurement in lymphocytes from healthy young
men [11]. In comparison, oesophageal cancer patients (n
= 17) showed higher oxidative DNA damage as indi-
cated by the 8-oxodG levels of 7.2 ± 2.6 per 10
6,2 ’-dG
(Student’st - t e s t ,P < 0.001). This difference remained
significant even after technical (storage, sampling period,
2’-dG levels) and individual (age, sex, smoking, alcohol)
confounding factors were taken into account (P <
0.0001, generalized linear regression model). Moreover,
data on smoking habits and alcohol consumption of the
volunteers were available, and could be correlated with
the observed levels of oxidatively-damaged DNA.
The aim of the present study was to characterize the
relationship between the levels of oxidative stress,
antioxidant vitamins and genetic constitution in oeso-
phageal cancers. An elevated level of oxidative DNA
lesions could be related to exogenous or endogenous
parameters. Therefore, factors that may influence the
extent of oxidative DNA damage such as the nutritional
status and genetic polymorphisms were included in this
study.
Antioxidant vitamins, such as vitamin A and vitamin E
are effective free radical scavengers and can also be use-
ful markers of antioxidant status. Presumably, a higher
production of ROS due to severe oxidative stress, char-
acteristic of oesophageal cancers, could lead to a higher
metabolic consumption of the antioxidant vitamins, and
this would be reflected in their lower serum levels. This
“antioxidant hypothesis” was examined in the subjects
included in our study by determining the serum concen-
trations of vitamins A and E.
Oxidatively damaged bases in DNA are preferentially
repaired by base excision enzymes. The hOGG1 gene
encodes the human 8-oxo-guanine DNA glycosylase
that cleaves the 8-oxo-guanine base from damaged
DNA. The single-nucleotide polymorphism at codon
326 (Ser326, rs 1052133) is the most well-studied poly-
morphism of hOGG1. Homozygous carriers of the var-
iant form of the hOGG1 Ser326Cys gene appear to have
a reduced capacity to repair oxidised DNA lesions
[12-14], although this is controversial [15]. A genetic
susceptibility toward SCC of the oesophagus linked to
the Ser326Cys polymorphism in the hOGG1 gene has
been described [16]. We have measured this polymorph-
ism in our population and correlated it with the corre-
sponding 8-oxodG level.
Polymorphism also exists in genes encoding enzymes
involved in the metabolism of xenobiotics that act as an
indirect source of free radicals. Genetic polymorphisms
in genes involved in detoxification such as glutathione-
S-transferases (GST), GSTM1, GSTT1 and GSTP1 could
potentially affect the susceptibility of an individual to
the adverse effects of environmental risk factors involved
in oesophageal cancer. The above three genes, are
expressed in the oesophageal mucosa. We have earlier
reported a significant increase in the risk of oesophageal
cancers correlated with the null genotypes of GSTM1
and GSTT1 but not with the GSTP1 Ile/Val polymorph-
ism [17]. The polymorphisms in the GST genes were
analysed according to their histological status, among
controls and cases of oesophageal cancers. These poly-
morphisms were revisited in the present study to inves-
tigate their correlation with the levels of 8-oxodG.
Methods
Patients and controls
Following an approval from the ethical committee
(Comité Consultatif pour la Protection des Personnes en
Recherche Biomédicale, Basse-Normandie), consenting
patients and control subjects were recruited between
1996 and 2000 within the context of a case-control
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suitable for molecular epidemiology of oesophageal can-
cers [17]. The control group (n = 43) included healthy
donors, who had no clinical history of chronic diseases
or cancer and were living in the Lower Normandy,
France. Seventeen oesophageal cancer patients from the
University Hospital of Caen, France, were selected based
on the availability of biological samples. Diagnosis was
performed at the Department of Hepato-gastroenterol-
ogy, University Hospital of Caen, France, and the
Department of Anatomopathology, François Baclesse
Center, Caen, France. Out of the 17 patients, 9 pre-
sented with SCC, 7 with ADC and 1 with leiomyoma, a
rare histological subtype. All cases were newly diagnosed
and previously untreated. Individual data related to age,
sex, alcohol consumption and smoking habits of the
subjects have been published earlier [10] and are sum-
marized in Table 1. Twenty ml of venous blood samples
were collected before performing any procedure such as
surgery, radio- or chemotherapy. The PBMCs were
separated and used for quantification of 8-oxodG and
genetic polymorphisms from blood samples of all indivi-
duals (n = 60), while the serum was used for quantifica-
tion of the vitamins A and E from all except three
samples (n = 57), for which the volumes were
insufficient.
PBMC collection, DNA isolation and hydrolysis
Care was taken to avoid artefactual oxidation of DNA
during its extraction and hydrolysis. PBMCs were iso-
lated from 12 ml out of the 20 ml blood samples using
Unisep Maxi tubes (Novamed). These were stored in
liquid nitrogen until being used for DNA isolation. Lat-
ter was performed using the “protocol G” described by
Ravanat et al. [18] with modifications aimed at optimi-
sation of the analytical procedure with minimum delays
[10]. Other modifications included addition of desfer-
rioxamine to extraction and digestion buffers.
8-oxodG HPLC-ED analysis
An optimised method for the quantification of 8-oxodG
in PBMCs has been described previously [10]. Briefly,
the DNA hydrolysate was analysed by HPLC with an
electrochemical detector (Coulochem II; ESA Inc.,
Chelmsford, MA) using a Supelcosil reversed-phase C18
HPLC column (150 × 3 mm, 5 μm -Supelco) equipped
with a C18 guard column. The eluant was 10 mM
potassium dihydrogen phosphate, pH 4.6, containing
7.5% methanol, at a flow rate of 0.6 ml/min. The poten-
tials applied to the analytical cell (ESA 5011) were + 50
mV and + 350 mV for E1 and E2, respectively. 2’dG was
measured in the same run of corresponding 8-oxodG
with a UV detector (Pharmacia LKB VWM 2141) at 290
nm situated after the ED cell. Acquisition and quantita-
tive analyses of chromatograms were carried out using
Eurochrom 2000 software (Knauer). The amount of 8-
oxodG in DNA was calculated as the number of 8-
oxodG molecules/10
6 unmodified 2’dG.
HPLC determination of serum vitamin A and E
Concentrations of vitamins A and E were measured in
the sera obtained from the blood samples of all subjects,
except for 3 (1 control, 2 patients). The serum fraction
was obtained after the isolation of PBMCs from blood
by centrifugation at 1000 × g for 20 min. Samples from
control and cancer subjects were stored in the same
conditions, at -80°C for several years until analysis.
Simultaneous determination of vitamin A and E was
performed by HPLC as previously described [19], with
the following modifications. The HPLC system consisted
of a Summit Dual Gradient System including a diode
array detector from Dionex (Voisin le Bretonneux,
France). The stationary phase consisted of a LiChro-
CART® 125-4 LiChrospher® 100 RP-18, 5 μmp r o t e c t e d
by a guard column filled with the same stationary phase
both from Merck Chemicals, France. The mobile phase
consisted of methanol and the flow rate was 0.8 ml/min.
Separations were carried out at 25°C. Vitamin A and E
peaks were integrated at 294 nm and the specificity of
the detection was based on retention factors and com-
parison of UV-Visible spectra with those collected from
the standard samples. For the calibration of the method
and for quality control we used lyophilised standard and
quality control serums from RECIPE (Munich, Ger-
many).100 μL of samples of either serum or a standard
solution or quality control sample, were added to 200
μL of a solution of ethanol containing tocopheryl acetate
(4 μM) that was used as an internal standard. After stir-
ring the mixture for 30 seconds, the vitamins were
extracted with 1000 μL of hexane (2 min of stirring).
The organic phase was evaporated under nitrogen and
the residues dissolved in 200 μL of methanol and 50 μL
were injected into the chromatograph. All procedures
were performed in a room with glass windows that pre-
vented penetration of direct sunlight.
GSTM1, GSTP1, GSTT1 and hOGG1 genotyping analysis
DNA was extracted by the phenol-chloroform method
using an aliquot out of the 20 ml venous blood samples
Table 1 Description of individual data
Parameter Controls (43) Patients (17)
Age (years) 64 ± 8 63 ± 9
Sex men/women 27/16 14/3
Smoking (cigarettes per week) 52 ± 79
a 113 ± 97
b
Alcohol (grams/week) 143 ± 140
a 289 ± 258
b
Numbers represent values for mean ± standard deviation;
a: n = 36;
b: n = 10.
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GSTT1 polymorphisms in the 60 subjects was per-
formed as previously described [17]. Analysis of deletion
polymorphism in GSTM1 and GSTT1 was performed by
multiplex PCR and that of single nucleotide polymorph-
ism in GSTP1by a PCR-RFLP method as previously
described [20]. In addition to these polymorphisms, sub-
jects were also genotyped for the presence of either the
serine or cysteine codon at position 326 (rs 1052133) of
the hOGG1 gene by PCR-RFLP, using primers and con-
ditions as previously described [21]. Briefly, the PCR
amplification of the 293 bp fragment consisted of a 15-
min denaturation at 95°C followed by 30 cycles of 95°C
for 1 min, 50°C for 1 min and 72°C for 1 min. A final
extension step of 72°C for 10 min was included. We
used a simple RFLP method to identify the Ser326Cys
by virtue of an Fnu4HI restriction site. The hOGG1
PCR product was digested with Fnu4HI overnight at 37°
C. Recovery of two digested fragments (123/124bp and
169/170bp) indicated presence of the Cys326 allele,
while an undigested amplicon indicated the Ser326
allele.
Statistical analysis
All statistics and graphics have been performed with the
SAS System release 9 (SAS Institute Inc., Cary, NC,
USA). Distributions of 8-oxodG were normalised by
logarithmic transformations. Mean values were com-
pared by Student’s t-test or ANOVA and correlations
between 8-oxodG and antioxidants were evaluated by
Pearson correlation test. All statistical analyses were
two-sided.
Results
Blood levels of 8-oxodG and vitamins A and E
The mean serum concentrations of vitamin A were 2.77
μM and 2.74 μM, while those for vitamin E were 34.77
μM and 38.73 μM, in patients and controls respectively
(Table 2).
There was a high intersample variability in the levels
of vitamins across subjects, as indicated by the wide
range of values. The mean values in the subjects were in
the range of values reported recently by others for these
vitamins [22-25]. There were no significant differences
in the levels of vitamins A and E between the control
and cases. Further, there was no significant correlation
found between the levels of 8-oxodG and those of vita-
min A (R = 0.1425; P = 0.290) or vitamin E (R = 0.0321;
P = 0.813) when cases and controls were combined
(Pearson correlation test, two-sided). However, a posi-
tive correlation between the levels of 8-oxodG and vita-
min A (R = 0.5714; P = 0.026) and vitamin E (R =
0.4834; P = 0.068) was observed when only cases (n =
17) were taken into account (Figure 1).
Levels of 8-oxodG and hOGG1 polymorphism
The potential relationship between 8-oxodG and the
Ser326Cys polymorphism in the hOGG1 gene was exam-
ined in the pooled population of cases and controls.
Comparisons of means of 8-oxodG between genotypes
were done with ANOVA after logarithmic transforma-
tion. As shown in Figure 2, there was no statistically sig-
nificant association between levels of 8-oxodG in DNA
and hOGG1 Ser326Cys polymorphism (P =0 . 6 3 7 ) .T h e
prevalence of the Cys allele, hOGG1
326Cys, was 0.27 in
the controls and 0.09 in the cases (Table 3).
Levels of 8-oxodG and frequency of GST alleles
The level of 8-oxodG according to GST polymorphisms
was examined in the pooled population after logarithmic
transformation. There was no difference with the null
genotypes of the GSTM1 (Student t test; P = 0.982), and
GSTT1 (Student t test; P = 0.345), whereas there was a
strong difference between GSTP1 variants (ANOVA, P
< 0.0001) (Figure 3).
Discussion
Oxidative damage to DNA is considered to be an
important risk factor for carcinogenesis. 8-oxodG is a
key biomarker in this process because it is one of the
most frequently encountered product of oxidatively-
damaged DNA and also one that can be easily detected
in samples of tissues or urine [26-30]. We have pre-
viously reported a significantly higher level of 8-oxodG
in circulating blood cells from oesophageal cancer
patients compared to control subjects [10]. Similar
observations have been made for colorectal carcinoma
[31], lung cancer [22,24,32] and leukaemia [33,34]. In
Table 2 Biochemical parameters of the study group
Parameter Patients (mean ± s.d.) Controls (mean ± s.d.) P-value
b
patient vs. control
8-oxodG/10
6 2’dG
c 7.2 ± 2.6 (n=1 7 ) 4.9 ± 1.9 (n=4 3 ) P < 0.001
Vitamin A (μM) 2.77 ± 0.94 (n=1 5 )
a 2.74 ± 0.61 (n=4 2 )
a P = 0.895
Vitamin E (μM) 34.77 ± 12.27 (n=1 5 )
a 38.73 ± 9.47 (n=4 2 )
a P = 0.204
PBMCs were collected and processed for measuring 8-oxodG. Vitamins were extracted from the serum samples for estimation.
a Numbers in parentheses indicate
the number of samples analysed as some samples had to be omitted due to insufficient volume of serum collected. A total of 57 out of the 60 samples were
analysed for vitamins.
b Student’s t-test was applied.
c Values taken from our data published earlier [10].
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smoking, alcohol, sex or age, was shown to influence 8-
oxodG concentrations. The aim of the present study
was to identify other factors that could modulate 8-
oxodG levels. We have attempted to characterize the
relationship between oxidative stress, evaluated in terms
of levels of 8-oxodG in PBMCs, and the levels of antiox-
idant vitamins and the genetic constitution, in a popula-
tion consisting of healthy volunteers and oesophageal
cancer patients.
Vitamin C, vitamin E, carotenoids, and other antioxi-
dants present in fruits and vegetables could contribute
to cancer prevention by protecting DNA from oxidative
damage, according to the “antioxidant hypothesis”.B y
inference, the endogenous levels of these antioxidant
vitamins in the serum of oesophageal cancer patients
are expected to be low. Likewise, under conditions of
severe oxidative stress also, their serum levels may be
low as these would be consumed in redox reactions
involving ROS.
Many recent epidemiological studies have confirmed
that a high intake of fruits and vegetables is associated
with a decreased risk of upper aero-digestive tract can-
cers [4,35-37]. One of the possible mechanisms of this
protective effect is the antioxidant activity of vitamins A,
C and E. These vitamins are effective antioxidants in
vitro, and might be expected to protect against cancer.
Calişkan-Can et al. [24] found lower levels of b-carotene
and vitamins A, C and E in lung cancer patients com-
pared to healthy controls. Foksinski et al. [23] observed
that the mean levels of all the measured antioxidant
vitamins were significantly lower in smokers in
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Figure 1 Correlation between 8-oxodG levels and vitamin A (a) and vitamin E (b) in cancer patients group (n = 15). 8-oxodG level is
expressed as the number of molecules of 8-oxodG per 10
6 2’dG; R = 0.5714 and P = 0.026 for correlation between 8-oxodG and vitamin A; and
R = 0.4834 and P = 0.068 for correlation between 8-oxodG and vitamin E; Log of 8-oxodG (Y-axis) is plotted against vitamin A and E
concentrations as indicated; circles, values for individual data; full line, linear regression; dotted line, 95% confidence limit.
L
o
g
 
8
-
o
x
o
d
G
 
 
 
 
 
 
         Cys/Cys         Ser/Cys           Ser/Ser 
hOGG1 Cys/Cys         Ser/Cys           Ser/Ser 
 n= 2    n= 22    n= 36 
hOGG1
Figure 2 Levels of 8-oxodG according to hOGG1 genotypes. Data from patients and controls were combined (n = 60) and analyzed by
ANOVA (P=0.637). 8-oxodG level is expressed as the number of molecules of 8-oxodG per 10
6 2’dG and Log of 8-oxodG (Y-axis) is plotted
against frequencies of hOGG1 genotypes as indicated. circles, values of individual sample.
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Page 5 of 10comparison with non-smokers. Gackowski et al. [22]
reported that vitamin E levels were significantly reduced
in the plasma of lung cancer patients (smokers and ex-
smokers) compared to healthy smokers and that the
levels of vitamins A and E in plasma of colorectal carci-
noma patients were lower than in the control group
[31]. In contrast, other studies found no significant dif-
ferences between healthy smokers and non-smokers for
either serum vitamin A or vitamin E [22,38,39]. Also,
several large-scale antioxidant supplementation trials
have failed to show any clear evidence for a decrease in
cancer risk [30,40]. In our study, we found that the
endogenous serum levels of vitamins A and E were simi-
lar in oesophageal cancer patients and in controls. Nota-
bly, despite the fact that our study subjects come from
the same geographical area, there was substantial inter-
sample variability, especially for the cancer cases. These
differences could reflect the balance between absorption
and tissue secretion, and may also be genetically deter-
mined. A recording of dietary habits (fruit and vegetable
consumption) could have added a complementary and
an interesting feature to our study. Determination of the
two major water-soluble antioxidants, ascorbate and glu-
tathione would also have brought complementary infor-
mation. However, as particular conditions are required
for sample collection, processing and storage to prevent
their oxidation and degradation, these could not be ana-
lysed in this retrospective study.
Correlation between the levels of vitamins and 8-
oxodG has been reported. In their analyses of 30 cross-
sectional studies, Moller & Loft [41] identified 12 stu-
dies showing an inverse correlation between oxidatively
damaged DNA and antioxidant levels, 16 reporting no
correlation and two, a positive correlation. A lack of a
correlation between 8-oxodG and antioxidant vitamins
has also been reported by others [22,35,42]. In a recent
paper, Sram et al. [43] found a negative correlation
between 8-oxodG and b-carotene and vitamin E but a
weak positive association with vitamin A. Similar posi-
tive correlations were reported for vitamin A in chemi-
cal workers exposed to vinyl chloride monomer [44],
carotenoids and vitamin E [45]. We did not find any
correlation between the levels of 8-oxodG and vitamins
in our study group (cases and controls combined).
Interpretation of these correlative data must be made
with extreme caution because the precise effects of anti-
oxidants on mutagenesis and carcinogenesis remain
unclear. An antioxidant, including a vitamin antioxidant,
is essentially a redox (reduction-oxidation) agent that
provides protection against free radicals, but may pro-
mote free radical generation under certain circum-
stances or may exert pro-oxidant effects. Conversely,
recent meta-analysis on supplementation trials indicates
increased risk of mortality [40], suggesting a pro-oxidant
activity at high doses or in cancer-risk subjects (smokers
and workers exposed to asbestos). Further, besides
Table 3 Genotype frequency of hOGG1 Ser326Cys in
patients with oesophageal cancer
Genotype Controls (n =
43)
(%)
Patients (n =
17)
(%)
Total (n =
60)
(%)
Ser/Ser 22 (51) 14 (82) 36 (60)
Ser/Cys 19 (44) 3 (18) 22 (37)
Cys/Cys 2 (5) 0 2 (3)
Cys allele
frequency
0.27 0.09 0.22
Numbers in parentheses represent the relative percentage in the group.
GSTM1                                    GSTP1                               GSTT1 
Log 8-oxodG                 Log 8-oxodG                         Log 8-oxodG                  
        GSTM1*2/2      Wild type                Ile/Ile       Ile/Val     Val/Val              GSTT1*2/2      Wild type 
                 n= 28             n= 22             n= 24         n= 21       n= 13            n= 10    n= 39    
Figure 3 Levels of 8-oxodG according to genotypes of GSTM1, GSTP1 and GSTT1. Data from patients and controls were combined (n =
60). 8-oxodG level is expressed as the number of molecules of 8-oxodG per 10
6 2’dG and Log of 8-oxodG (Y-axis) is plotted against frequencies
of the various genotypes as indicated, GSTM1 (P = 0.982), GSTP1 (P < 0.0001 for Val/Val vs Ile/Ile and Ile/Val) and GSTT1 (P = 0.345); circles:
values for individual data.
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eactive substances in natural products likely contribute
to the protection of DNA from damage and thus influ-
ence the generation of 8-oxodG in vivo. The number of
such antioxidants exceeds that of antioxidant vitamins.
The availability of these unidentified antioxidants in
individual diet could thus affect the correlation between
levels of 8-oxodG and antioxidant vitamins. Some diet-
ary components also could up-regulate DNA repair
without having any recognised antioxidant function.
Interestingly, a positive association was observed in our
study between the levels of 8-oxodG and those of the
two vitamins, but only in the cases and not in the con-
trols. However, this observation should be interpreted
with caution, in the light of the foregoing discussion.
Moreover, to arrive at a more convincing conclusion,
our data would have to be expanded and adjusted for
possible confounders such as age which can become the
predominant, independent determinant of oxidative
damage as has been discussed recently [43].
In view of the conflicting reports in the literature and
the results of the present study, the “antioxidant hypoth-
esis” seems open to criticism. Is there indeed a relation-
ship between antioxidant vitamins and oxidatively-
damaged DNA? Secondly, are the concentrations of
antioxidants and 8-oxodG in the blood representative
measures of the situation in the target tissue of the car-
cinogenesis and a true reflection of overall cellular DNA
damage? Thirdly, do we have reliable tools to examine
this correlation? The choice and reliability of biomarkers
such as 8-oxodG has also been debated [28,30,46]. The
reliability of 8-oxodG is influenced by its method of
detection since its artefactual production is a serious
concern. Notably, the values of 8-oxodG reported in this
study are low and reach the background level of 8-
oxodG recommended by ESCODD for HPLC-ED mea-
surement, indicating that these were not an artefact.
It is known that individuals have different responses to
oxidative damage and that the risk for oxidative stress-
related cancer varies according to both, the environmen-
tal exposure and the genetic background. The human 8-
oxoguanine DNA glycosylase1 (hOGG1) is one of the
major enzymes involved in DNA base excision repair
(BER). A positive relationship between hOGG1 mRNA
expression and 8-oxodG suggests that the expression
level of hOGG1 may be interpreted as a biomarker of
exposure to oxidative DNA damage [47,48]. On the
other hand, some studies indicated that there was no
interaction between these parameters [12,49,50], which
could be explained by the fact that hOGG1 is weakly
expressed in certain tissues such as the aerodigestive
tract tissue [51].
T h ea c t i v i t yo fh O G G 1c a nb ei m p a i r e db yap o l y -
morphic mutation at codon 326, the hOGG1 Ser326Cys
polymorphism. However, the phenotypic impact of
hOGG1 Ser326Cys polymorphism is unclear. Recent
data have shown that the hOGG1 Ser326Cys polymorph-
ism is associated with a reduced DNA repair capacity
for oxidatively-damaged DNA [52], whereas according
to others, the converse is true [15,53,54]. This led to the
conclusion that both, wild type and the hOGG1Cys326
variant-encoded proteins should be functional and prob-
ably do not exhibit significant differences in repair activ-
ities and hence the polymorphism at codon 326 would
probably be neutral [53,55].
Many epidemiological studies have investigated the
association of the Ser326Cys polymorphism in the
hOGG1 gene indicating an increased risk for head and
neck cancers but the reports are conflicting [51,56,57].
Studies on the prevalence of this polymorphism in sus-
ceptibility to oesophageal cancer also show conflicting
results. Xing et al. [16] reported a positive association
between the Cys326 variant and oesophageal cancer risk
in Asians population whereas Tse et al. [58] reported no
association in Caucasians. In the present study, the
small number of samples did not allow us to make a
comparison of the genotype distribution between cases
and controls in order to determine whether the
hOGG1
326Cys allele contributed to the risk of oesopha-
geal cancer. However, the distribution of hOGG1
Ser326Cys genotype in our controls (0.44) is in agree-
ment with the frequencies previously described in Cau-
casian population. This frequency is classically lower
than that in Asians [21,51,59], suggesting that this allele
may be differently distributed among ethnic groups and
may not confer a particular susceptibility to oesophageal
cancer in Caucasian population. The allelic distribution
of this polymorphism in our combined population fol-
lowed Hardy-Weinberg equilibrium.
Besides DNA repair activity, enzymes involved in the
detoxification of xenobio t i c ss u c ha sg l u t a t h i o n e
S-transferases may influencet h ee x t e n to fo x i d a t i v e
damage in humans. We genotyped our study popula-
tion for the GSTM1, GSTT1 and GSTP1 genes. Our
results indicate no association between GSTM1 and
GSTT1 null polymorphisms and 8-oxodG levels in
DNA from PBMCs. On the other hand, we found a
statistically significant association between GSTP1 Val/
Val homozygote carriers and a high level of 8-oxodG
(Figure 2). However, as no obvious relationship was
found between the frequency of the Val allele (Val/Val
and Ile/Val combined) and the level of 8-oxodG, we
consider this result questionable. Indeed, correlation of
GST polymorphisms with 8-oxodG levels in WBCs or
lymphocytes varies with the context of exposure: poly-
cyclic aromatic hydrocarbons [60,61], benzene [62],
fine particulate matters [63] and hyperbaric oxygen
[64].
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In conclusion, although the power of our study is lim-
ited, it seems likely that vitamin levels in serum and
polymorphisms in the hOGG1 or GST genes are not
important modulators of 8-oxodG levels. Further studies
in a larger cohort of patients using other biomarkers of
oxidative damage and antioxidant status are required to
better understand the possible involvement of oxidative
stress in oesophageal cancer.
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